Vontobel Holding’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
VPM
VCM
EC
Vontobel Holding's JAZZ Position: Q1 2026 in Review
Vontobel Holding reduced its Jazz Pharmaceuticals (JAZZ) stake by 27% in Q1 2026, selling an estimated $112K and leaving 1,776 shares worth $336K. The position accounts for ﹤0.01% of the portfolio, ranked #972.
Vontobel Holding first reported a position in JAZZ in Q2 2021 and has held it in 20 quarters since. The position peaked at $754K in Q1 2024. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- Vontobel Holding held 1,776 shares of Jazz Pharmaceuticals worth $336K as of Q1 2026.
- Vontobel Holding sold 641 Jazz Pharmaceuticals shares in Q1 2026, an estimated $112K.
- Jazz Pharmaceuticals made up ﹤0.01% of Vontobel Holding's portfolio in Q1 2026, its #972 holding.
- Vontobel Holding first reported a position in Jazz Pharmaceuticals in Q2 2021 and has held it in 20 quarters since.
- Vontobel Holding's Jazz Pharmaceuticals position peaked at $754K in Q1 2024.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on Vontobel Holding's 13F filing for Q1 2026, filed 8 May 2026.